<p>The current investigation aimed to identify potentially effective phytocompounds within the methanolic leaf extract of <i>Sarcochlamys pulcherrima</i> as inhibitors of Penicillin Binding Protein 4 of <i>Staphylococcus aureus</i>, using an in-silico methodology. Gas Chromatography–Mass Spectrometry analysis revealed forty-four compounds, from which thirteen major compounds were selected for in silico analysis. Notably, among these, Ginsenol not only passed all drug-likeness filters but also demonstrated promising pharmacokinetic, lipophilicity, physiochemical and solubility properties, rendering it highly drug-like. Molecular docking and molecular dynamics simulation findings suggest that Ginsenol has the potential to inhibit Penicillin Binding Protein 4, making it a promising lead compound for the development of new antibacterial formulations against<i> Staphylococcus aureus.</i></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

In silico analysis of phytocompounds from Sarcochlamys pulcherrima against molecular drug target of Staphylococcus aureus

  • Rajesh Kumar Shah,
  • Mouchurisha Deori,
  • Leeza Das,
  • Modhumita Karmakar

摘要

The current investigation aimed to identify potentially effective phytocompounds within the methanolic leaf extract of Sarcochlamys pulcherrima as inhibitors of Penicillin Binding Protein 4 of Staphylococcus aureus, using an in-silico methodology. Gas Chromatography–Mass Spectrometry analysis revealed forty-four compounds, from which thirteen major compounds were selected for in silico analysis. Notably, among these, Ginsenol not only passed all drug-likeness filters but also demonstrated promising pharmacokinetic, lipophilicity, physiochemical and solubility properties, rendering it highly drug-like. Molecular docking and molecular dynamics simulation findings suggest that Ginsenol has the potential to inhibit Penicillin Binding Protein 4, making it a promising lead compound for the development of new antibacterial formulations against Staphylococcus aureus.